Foreword | p. xiii |
Acknowledgments | p. xiv |
Symptoms in Older Adults | p. 1 |
Case Study | p. 1 |
Overview | p. 1 |
Overview of Normal Aging | p. 2 |
Common Health Issues in the Aging Population | p. 4 |
Cancer-Related Symptom Issues | p. 6 |
Pharmacologic Management | p. 9 |
Nonpharmacologic Management | p. 11 |
Symptom Management Outcomes | p. 12 |
Need for Future Research | p. 12 |
Conclusion of Case Study | p. 12 |
Conclusion | p. 13 |
References | p. 14 |
Alopecia | p. 17 |
Case Study | p. 17 |
Overview | p. 17 |
Pathophysiology | p. 18 |
Hair Loss During Cancer Treatment | p. 19 |
Preventing Hair Loss | p. 20 |
Human Responses to Hair Loss | p. 22 |
Clinical Practice Recommendations | p. 23 |
Conclusion of Case Study | p. 24 |
Conclusion | p. 25 |
References | p. 25 |
Anemia | p. 29 |
Case Study | p. 29 |
Overview | p. 29 |
Pathophysiology | p. 30 |
Assessment | p. 35 |
Evidence-Based Interventions | p. 37 |
Standing Orders | p. 42 |
Expected Outcomes | p. 42 |
Patient Teaching Points | p. 44 |
Need for Future Research | p. 44 |
Conclusion of Case Study | p. 45 |
Conclusion | p. 45 |
References | p. 45 |
Anxiety and People With Cancer | p. 49 |
Case Study | p. 49 |
Overview | p. 49 |
Incidence | p. 50 |
Pathophysiology | p. 52 |
Assessment | p. 53 |
Measurement | p. 54 |
Evidence-Based Interventions | p. 54 |
Psychosocial Interventions | p. 55 |
Pharmacologic Interventions | p. 56 |
Complementary Therapies | p. 60 |
Expected Outcomes | p. 60 |
Patient Teaching Points | p. 60 |
Need for Future Research | p. 61 |
Conclusion of Case Study | p. 62 |
Conclusion | p. 62 |
References | p. 62 |
Cancer Cachexia | p. 65 |
Case Study | p. 65 |
Overview | p. 65 |
Pathophysiology | p. 66 |
Assessment | p. 69 |
Treatment | p. 71 |
Evidence-Based Interventions | p. 72 |
Patient Teaching Points | p. 82 |
Need for Future Research | p. 83 |
Conclusion of Case Study | p. 83 |
Conclusion | p. 84 |
References | p. 84 |
Chemotherapy-Induced Nausea and Vomiting | p. 91 |
Case Study | p. 91 |
Overview | p. 91 |
Prevalence of Chemotherapy-Induced Nausea and Vomiting | p. 93 |
Pathophysiology | p. 94 |
Impact of Chemotherapy-Induced Nausea and Vomiting | p. 96 |
Risk Factors | p. 98 |
Continuation of Case Study | p. 101 |
Assessment | p. 101 |
Evidence-Based Interventions | p. 103 |
Nonpharmacologic Management | p. 112 |
Need for Future Research | p. 114 |
Conclusion of Case Study | p. 115 |
Conclusion | p. 116 |
References | p. 116 |
Cognitive Impairment | p. 123 |
Case Study | p. 123 |
Overview | p. 123 |
Descriptions and Consequences of Cognitive Impairment | p. 124 |
Pathophysiology | p. 125 |
Assessment | p. 129 |
Interventions | p. 131 |
Patient Teaching Points | p. 132 |
Need for Future Research | p. 134 |
Conclusion of Case Study | p. 134 |
Conclusion | p. 135 |
References | p. 135 |
Constipation | p. 139 |
Case Study | p. 139 |
Overview | p. 139 |
Pathophysiology | p. 141 |
Assessment | p. 143 |
Management and Evidence-Based Interventions | p. 145 |
Prevention | p. 147 |
Laxatives | p. 148 |
Enemas | p. 149 |
Nonpharmacologic Interventions | p. 150 |
Obstipation | p. 150 |
Patient Teaching Points | p. 150 |
Need for Future Research | p. 151 |
Conclusion of Case Study | p. 151 |
Conclusion | p. 152 |
References | p. 152 |
Depression | p. 153 |
Case Study | p. 153 |
Overview | p. 153 |
Pathophysiology | p. 155 |
Assessment | p. 156 |
Evidence-Based Interventions | p. 158 |
Patient Teaching Points | p. 166 |
Need for Future Research | p. 167 |
Conclusion of Case Study | p. 168 |
Conclusion | p. 169 |
References | p. 169 |
Diarrhea | p. 173 |
Case Study | p. 173 |
Overview | p. 173 |
Definition | p. 173 |
Incidence | p. 174 |
Risk Factors | p. 176 |
Pathophysiology | p. 177 |
Causes | p. 177 |
Osmotic Diarrhea | p. 178 |
Malabsorptive Diarrhea | p. 178 |
Secretory Diarrhea | p. 178 |
Infectious Diarrhea | p. 180 |
Dysmotility-Associated Diarrhea | p. 180 |
Chemotherapy-Induced Diarrhea | p. 181 |
Radiation-Induced Diarrhea | p. 182 |
Assessment | p. 182 |
Evidence-Based Interventions | p. 186 |
Nonpharmacologic Interventions | p. 187 |
Pharmacologic Interventions | p. 190 |
Expected Outcomes | p. 193 |
Patient and Family Teaching Points | p. 194 |
Need for Future Research | p. 194 |
Conclusion of Case Study | p. 195 |
Conclusion | p. 195 |
References | p. 195 |
Dyspnea | p. 199 |
Case Study | p. 199 |
Overview | p. 199 |
Assessment | p. 202 |
Evidence-Based Interventions | p. 208 |
Expected Outcomes | p. 215 |
Patient Teaching Points | p. 215 |
Need for Future Research | p. 218 |
Conclusion of Case Study | p. 219 |
Conclusion | p. 220 |
References | p. 220 |
Electrolyte Imbalances, Tumor Lysis Syndrome, and Syndrome of Inappropriate Antidiuretic Hormone | p. 225 |
Case Study | p. 225 |
Electrolyte Imbalances | p. 225 |
Syndrome of Inappropriate Antidiuretic Hormone | p. 256 |
Tumor Lysis Syndrome | p. 260 |
Conclusion of Case Study | p. 267 |
Conclusion | p. 267 |
References | p. 267 |
Cancer-Related Fatigue | p. 271 |
Case Study | p. 271 |
Overview | p. 271 |
Pathophysiology | p. 274 |
Assessment | p. 276 |
Evidence-Based Interventions | p. 281 |
Expected Outcomes | p. 287 |
Patient and Family Teaching Points | p. 287 |
Need for Future Research | p. 288 |
Conclusion of Case Study | p. 289 |
Conclusion | p. 290 |
Reference | p. 290 |
Hot Flashes | p. 299 |
Case Study | p. 299 |
Overview | p. 299 |
Risk Factors | p. 300 |
Pathophysiology | p. 301 |
Assessment | p. 303 |
Evidence-Based Interventions | p. 303 |
Pharmacologic Interventions | p. 305 |
Nonpharmacologic Interventions | p. 307 |
Patient Teaching Points | p. 308 |
Need for Future Research | p. 308 |
Conclusion of Case Study | p. 309 |
Conclusion | p. 309 |
References | p. 309 |
Lymphedema | p. 315 |
Case Study | p. 315 |
Overview | p. 315 |
Quality of Life | p. 318 |
Pathophysiology | p. 319 |
Assessment | p. 321 |
Treatment | p. 322 |
Expected Outcomes | p. 328 |
Patient Teaching Points | p. 328 |
Need for Future Research | p. 329 |
Conclusion of Case Study | p. 329 |
Conclusion | p. 330 |
References | p. 330 |
Oral Mucositis | p. 333 |
Case Study | p. 333 |
Overview | p. 333 |
Risk Factors and Associated Incidence | p. 334 |
Pathophysiology | p. 336 |
Assessment | p. 338 |
Interventions | p. 339 |
Patient Teaching Points | p. 342 |
Expected Outcomes | p. 342 |
Need for Future Research | p. 343 |
Conclusion of Case Study | p. 343 |
Conclusion | p. 343 |
References | p. 344 |
Neutropenia and Infection | p. 347 |
Case Study | p. 347 |
Overview | p. 347 |
Definitions | p. 347 |
Risk Factors | p. 349 |
Pathophysiology | p. 351 |
Assessment | p. 351 |
Interventions | p. 353 |
Patient Teaching Points | p. 358 |
Need for Future Research | p. 359 |
Conclusion of Case Study | p. 359 |
Conclusion | p. 359 |
References | p. 359 |
Osteoporosis and Bone Health | p. 363 |
Case Study | p. 363 |
Overview | p. 363 |
Epidemiology: Prevalence and Impact | p. 364 |
Risk Factors | p. 365 |
Pathophysiology | p. 369 |
Screening | p. 372 |
Assessment | p. 372 |
Diagnosis | p. 373 |
Case Study (Part 2) | p. 375 |
Prevention and Treatment | p. 376 |
Case Study (Part 3) | p. 378 |
Pharmacologic Treatment | p. 378 |
General Principles of Treatment | p. 380 |
Patient Teaching Points | p. 380 |
Conclusion of Case Study | p. 381 |
Conclusion | p. 382 |
References | p. 382 |
Cancer Pain | p. 389 |
Case Study | p. 389 |
Overview | p. 389 |
Pathophysiology | p. 390 |
Assessment | p. 391 |
Evidence-Based Interventions | p. 392 |
Principles of Cancer Pain Management | p. 392 |
Pharmacologic Cancer Pain Management | p. 394 |
Nonpharmacologic Cancer Pain Management | p. 399 |
Expected Outcomes | p. 399 |
Patient Teaching Points | p. 399 |
Need for Future Research | p. 400 |
Conclusion of Case Study | p. 400 |
Conclusion | p. 401 |
References | p. 401 |
Peripheral Neuropathy | p. 405 |
Case Study | p. 405 |
Overview | p. 405 |
Definition | p. 406 |
Incidence | p. 407 |
Risk Factors | p. 408 |
Pathophysiology | p. 410 |
Characteristics of Peripheral Neuropathy | p. 411 |
Assessment | p. 411 |
Tests | p. 412 |
Grading | p. 414 |
Evidence-Based Interventions | p. 416 |
Expected Outcomes | p. 416 |
Patient Teaching Points | p. 417 |
Need for Future Research | p. 417 |
Conclusion of Case Study | p. 418 |
Conclusion | p. 419 |
References | p. 419 |
Altered Sexuality Patterns | p. 423 |
Case Study | p. 423 |
Overview | p. 423 |
Erectile Dysfunction | p. 424 |
Dyspareunia | p. 429 |
Altered Body Image | p. 433 |
Changes in Libido | p. 436 |
Infertility | p. 440 |
Expected Outcomes for Altered Sexuality Patterns | p. 447 |
Patient Teaching Points for Altered Sexuality Patterns | p. 448 |
Need for Future Research for Altered Sexuality Patterns | p. 449 |
Conclusion of Case Study | p. 449 |
Conclusion | p. 450 |
References | p. 450 |
Skin and Nail Alterations | p. 457 |
Case Study | p. 457 |
Overview | p. 457 |
Nail Bed Changes | p. 459 |
Hyperpigmentation | p. 461 |
Paronychia and Onycholysis | p. 462 |
Palms and Soles | p. 462 |
Incidence of Rash: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors | p. 463 |
Pathophysiology | p. 464 |
Assessment | p. 465 |
Interventions for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Rash | p. 466 |
Patient Teaching Points | p. 468 |
Need for Future Research | p. 469 |
Conclusion of Case Study | p. 469 |
Conclusion | p. 469 |
References | p. 470 |
Sleep-Wake Disturbances | p. 473 |
Case Studies | p. 473 |
Overview | p. 474 |
Sleep Physiology | p. 475 |
Sleep-Wake Disturbances in Patients With Cancer | p. 478 |
Assessment of Sleep-Wake Disturbances | p. 480 |
Evidence-Based Interventions | p. 482 |
Expected Outcomes | p. 489 |
Patient and Family Teaching Points | p. 489 |
Need for Future Research | p. 489 |
Conclusion of Case Studies | p. 490 |
Conclusion | p. 491 |
References | p. 491 |
Spiritual Care From the Oncology Nurse | p. 497 |
Case Study | p. 497 |
Overview | p. 497 |
Meaning of Spirituality | p. 497 |
What Patients Have to Say About the Spirit | p. 498 |
Prerequisites and Self-Care for Engagement in Spiritual Care | p. 499 |
Assessment of Spiritual Needs | p. 500 |
Application of FICA to Case Study | p. 502 |
Interventions | p. 502 |
Community-Based Spiritual Care | p. 506 |
Interventions in the Case Study | p. 506 |
Conclusion | p. 506 |
References | p. 507 |
Index | p. 509 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.